Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. May 28, 2012; 18(20): 2569-2575
Published online May 28, 2012. doi: 10.3748/wjg.v18.i20.2569
Published online May 28, 2012. doi: 10.3748/wjg.v18.i20.2569
Figure 2 Kaplan-Meier plots for predicting disease specific survival based on the modified National Institutes of Health consensus system (A), Ki-67 expression (B) and adjuvant imatinib therapy (C).
- Citation: Jiang J, Jin MS, Suo J, Wang YP, He L, Cao XY. Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors. World J Gastroenterol 2012; 18(20): 2569-2575
- URL: https://www.wjgnet.com/1007-9327/full/v18/i20/2569.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i20.2569